Postural Orthostatic Tachycardia Syndrome Clinical Trial
Official title:
Clinical Efficacy of High-Sodium Diet and External Abdominal Compression in the Treatment of Orthostatic Intolerance in POTS
The investigators will test to determine if an external Automated Abdominal Binder (non-commercial product) during high sodium diet improves orthostatic tolerance, compared to wearing the binder during a low sodium diet session.
The study will involve a crossover design in which each subject will be assessed (as below)
while on a very low-sodium (10 milliequivalent/day) diet compared with a very high-sodium
diet (300 milliequivalent/day). These acute dietary interventions will be part of the parent
study ("Dietary Salt in Postural Tachycardia Syndrome" IRB#111261) for 4-5 days at the time
of the study. Dietary success will be assessed using a 24h urine for sodium and creatinine
as a part of the parent study.
Study Day:
- Studies will be performed at the end of the low and high-sodium diet phases.
- Blood pressure recording will not begin until at least 2 hours after the last meal (to
avoid any confounding hypotension from the last meal).
- Subject will be asked to void prior to data collection.
- The subject will be seated in a chair, with their feet comfortably on the floor.
- The Dinamap electrocardiographic and blood pressure (brachial cuff) recorder will be
attached to the patient and set up for measurements every 10 minutes throughout the
study with digital download into the Autonomic Dysfunction Center BP database.
- After a 20-minute seated baseline, the subject will stand for up to10 minutes. Heart
rate and blood pressure (HR/BP) will be measured at 1, 3, 5, and 10 minutes of
standing. At the end of the baseline stand period, subjects will be asked to rate their
symptoms using the provided orthostatic intolerance Symptoms questionnaire.
- The subject will then be seated and the abdominal binder will be applied without
compression.
- The Dinamap electrocardiographic and blood pressure (brachial cuff) recorder will be
attached to the patient and set up for measurements every 10 minutes throughout the
study with digital download into the Autonomic Dysfunction Center BP database.
- At 1 and 2 hours post intervention, the subject will be asked to stand for up to 10
minutes while applying external automated abdominal binder compression (up to 40 mmHg).
HR/BP will be measured at 1, 3, 5, and 10 minutes of standing.
o If nursing staffing shortages make q1h standing difficult, then the subject should be
asked to stand at least at 2 hours post intervention.
- Study termination for that day.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05555771 -
Paediatric Syncope in the Emergency Department
|
N/A | |
Recruiting |
NCT05923840 -
Chemoreflex and Baroreflex Alterations Causing Postural Tachycardia Syndrome With Orthostatic Hyperpnea and Hypocapnia
|
N/A | |
Completed |
NCT05633407 -
Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS
|
Phase 2 | |
Completed |
NCT03930914 -
Vagus Nerve Stimulation in Treatment of Postural Orthostatic Tachycardia Syndrome
|
N/A | |
Recruiting |
NCT00865917 -
Cardiovascular Effects of Selective I(f)-Channel Blockade
|
Phase 2 | |
Recruiting |
NCT05741112 -
The Long COVID-19 Wearable Device Study
|
N/A | |
Recruiting |
NCT05454137 -
A Shared Medical Appointment Intervention for Quality of Life Improvement in POTS
|
N/A | |
Recruiting |
NCT05924646 -
CAlgary SAlt for POTS
|
N/A | |
Enrolling by invitation |
NCT05877534 -
Effects of Individual Tailored Physical Exercise in Patients With POTS After COVID-19 - a Randomized Controlled Study
|
N/A | |
Completed |
NCT01367977 -
Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life
|
||
Recruiting |
NCT04881318 -
Compression Garments in the Community With POTS
|
N/A | |
Recruiting |
NCT06292104 -
Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)
|
||
Completed |
NCT02171988 -
Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)
|
Phase 4 | |
Completed |
NCT01547117 -
Dietary Salt in Postural Tachycardia Syndrome
|
N/A | |
Completed |
NCT01563107 -
Dietary Sodium's Effect on Urinary Sodium and Dopamine Excretion in Patients With Postural Tachycardia Syndrome
|
N/A | |
Completed |
NCT01617616 -
Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects
|
N/A | |
Active, not recruiting |
NCT02281097 -
Transdermal Vagal Stimulation for POTS
|
N/A | |
Completed |
NCT00728026 -
Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome (CVS), Irritable Bowel Syndrome (IBS),Postural Orthostatic Tachycardia Syndrome (POTS), Functional Abdominal Pain (FAP) or Chronic Nausea
|
N/A | |
Recruiting |
NCT05481177 -
Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort
|
Phase 4 | |
Not yet recruiting |
NCT05914649 -
NC Testing in LC & POTS
|
N/A |